首页 › 阿尔茨海默病 › 得克萨斯州 › Beaumont
Beaumont TX 阿尔茨海默病临床试验
6项针对 阿尔茨海默病的研究正在 Beaumont及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
招募中2 期
- Gadolin Research, Beaumont
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
招募中3 期
- Gadolin Research, LLC, Beaumont
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
招募中2 期
- Gadolin Research ( Site 1032), Beaumont
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
招募中3 期
- Gadolin Research, Beaumont
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
招募中3 期
- Gadolin Research, Beaumont
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
招募中观察性研究欢迎健康志愿者
- Gadolin Research LLC, Beaumont
其他城市的 阿尔茨海默病试验
- Boston, MA26 项研究
- Orlando, FL25 项研究
- St. Louis, MO22 项研究
- New York City, NY21 项研究
- Miami, FL20 项研究
- Tampa, FL17 项研究
- Atlanta, GA16 项研究
- The Villages, FL15 项研究
- Philadelphia, PA15 项研究
- Phoenix, AZ15 项研究
- Indianapolis, IN14 项研究
- Los Angeles, CA14 项研究
Beaumont的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。